Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Aug 17;5(2):225-31.
doi: 10.1159/000354767. eCollection 2013.

Diphenylcyclopropenone-induced vitiligo in a patient with alopecia universalis

Hassan Riad  1 , Haya Al Mannai, Khalid Mansour, Khalifa Al Qaatri, Sharifa Al Dosari, Amina Al Obaidaly, Emad Sultan
Affiliations
Case Reports

Diphenylcyclopropenone-induced vitiligo in a patient with alopecia universalis

Hassan Riad et al. Case Rep Dermatol. .

Abstract

Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site. Here, we have a case where both disorders were reported to present in the same patient. Diphenylcyclopropenone (diphencyprone, DCP) is used in the treatment of alopecia areata and may induce vitiligo in some patients. We report on one case of vitiligo that was induced by DCP during therapy for alopecia universalis. Alopecia areata and vitiligo share many susceptibility genes. Follicular melanocyte destruction may represent the link between the two diseases.

Keywords: Alopecia; Diphenylcyclopropenone; Vitiligo.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photographs of the AU patient after the appearance of patches of vitiligo attributable to the application of DCP.
Fig. 2
Fig. 2
Photographs of the patient after therapy; notice the regrowth of hair and repigmentation of vitiligo in most of the affected areas.
See this image and copyright information in PMC

References

    1. Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc. 2004;9:73–78. - PubMed
    1. Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51:1206–1212. - PubMed
    1. Gaskoin G. Alopecia: vitiligo. Br Med J. 1873;1:642–643. - PMC - PubMed
    1. Klaber R. Vitiligo with associated alopecia areata. Proc R Soc Med. 1934;27:1577–1578. - PMC - PubMed
    1. Dhar S, Kanwar AJ. Colocalization of vitiligo and alopecia areata. Pediatr Dermatol. 1994;11:85–86. - PubMed

Publication types